Tango Therapeutics Logo

Tango Therapeutics

🇺🇸
TNGX
US87583X1090

Tango Therapeutics is a US-based biotechnology company specializing in the development of innovative cancer therapies. By utilizing targeted synthetic lethality approaches, the company identifies novel drug candidates to treat challenging tumor types and address significant unmet medical needs.

Next Quarterly Earnings

Tuesday, November 10, 2026
CW 46
Pre-Market
In 75 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 13, 2026

Stock Price

Frequently asked questions

When will Tango Therapeutics report its next quarterly earnings?

Tango Therapeutics is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Tango Therapeutics last report quarterly earnings?

Tango Therapeutics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.37 USD.

How often has Tango Therapeutics beaten expectations?

Tango Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the Tango Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.34
Actual:
Q2 2026
Missed
Estimate:-$0.32
Actual:-$0.37
Difference:-$0.05
Q1 2026
Missed
Estimate:-$0.31
Actual:-$0.32
Difference:-$0.01
Price reaction (1 day):-2.5 %
Price reaction (7 days):-17.4 %
Q4 2025
Beat
Estimate:-$0.32
Actual:-$0.29
Difference:+$0.03
Price reaction (1 day):+36.3 %
Price reaction (7 days):+38.9 %
Q2 2025
Beat
Estimate:-$0.07
Actual:$0.13
Difference:+$0.20
Q1 2025
Missed
Estimate:-$0.34
Actual:-$0.35
Difference:-$0.01

Earnings statistics

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-1.5%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Tango Therapeutics
Ticker Symbol
TNGX
ISIN
US87583X1090
Country
🇺🇸
USA
Sector